Avalo Therapeutics · 21 hours ago
VP, Head of Biometrics
Avalo Therapeutics is a clinical stage biotechnology company focused on developing treatments for immune-mediated inflammatory diseases. The Head of Biometrics will oversee biostatistics, data management, and statistical programming, ensuring high-quality data strategies and analyses that support clinical development decisions and regulatory submissions.
BiotechnologyTherapeutics
Responsibilities
Partner closely with internal study team and external CROs to ensure high-quality and timely deliverables for biostatistics, data management and programming
Contribute to regulatory submissions (INDs, NDAs, BLAs, global briefing documents) and participate in regulatory interactions with Health Authorities as required
Interfaces with CRO ensuring data and statistical reporting is secure and timely
Interprets study results and provide review of statistical summary reports of study results for accuracy and interpretation of data
Collaborates on implementation and analysis of all statistical aspects of research protocols
Provides statistical input into study design, sample size estimation, randomization schedules, and endpoint selection for clinical programs
Develops statistical analysis plans, including detailed textual description of planned analysis and mock-ups of data displays
Assists in development of CRFs, programming specifications, and additional study documents related to data flow and analyses
Performs statistical analyses, including hypothesis testing and modeling
Provides tabular and written summaries of analyses and statistical methodology
Reviews and provides comments on statistical summaries
Provides input to project timelines and ensures that project timelines for biostatistics deliverables are met
Ensures that project tasks are completed with acceptable quality
Attends team meetings and represents departmental needs for assigned projects
Ensures compliance with ICH, CDISC, and regulatory standards
May assist in developing policies and procedures (SOPs)
Additional tasks and projects as assigned
Qualification
Required
PhD or M.S. in Biostatistics, Statistics, or related quantitative field
Minimum 10 years of biostatistics/biometrics experience in clinical development, with strong preference for monoclonal antibody and/or immunology drug development experience
Proven leadership in late-stage trials and cross-functional team collaboration
Strong statistical programming in SAS
Excellent communication and collaboration skills with a team-oriented approach
Excellent presentation and writing skills
Ability to thrive in a small company environment: fast-paced, hands-on, collaborative, and adaptable
Self-motivated with a commitment to high quality, on-time deliverables
Demonstrated ability to identify and resolve issues and effectively manage timelines
Strong knowledge of clinical trial design, statistical methods, and regulatory requirements
Ability to synthesize results in graphic, oral, and written reports
Strong knowledge of GCPs, ICH, FDA, and CDISC regulatory requirements governing clinical studies
Demonstrated attention to detail and outstanding organization skills
Preferred
Experience working in a biotech environment
Experience working with CROs and managing outsourced statistical deliverables
Company
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Funding
Current Stage
Public CompanyTotal Funding
$231.5M2024-11-12Post Ipo Equity· $69.4M
2024-03-27Post Ipo Equity· $115.6M
2023-02-02Post Ipo Equity· $15M
Recent News
2025-11-07
Avalo Therapeutics
2025-11-03
Company data provided by crunchbase